Recommended Citation
Ramesh M, Yee J. Clostridioides difficile Infection in Chronic Kidney Disease/End-Stage Renal Disease. Advances in chronic kidney disease 2019; 26(1):30-34.
Document Type
Article
Publication Date
1-1-2019
Publication Title
Advances in chronic kidney disease
Abstract
Clostridioides difficile infection (CDI) is a major health-care burden and increasingly seen in patients with chronic kidney disease (CKD) and end-stage renal disease (ESRD). Increased antibiotic use, alteration in host defenses, and gastric acid suppression are some of the etiologies for increased risk of CDI in these populations. Patients with CKD/ESRD have a higher risk of initial episode, recurrence, and development of severe CDI than those without CKD or ESRD. Diagnosis and management of CDI in patients with CKD/ESRD are similar to that in the general population. The mortality, length of stay, and health-care costs are higher in patients with CDI and CKD/ESRD. Antimicrobial stewardship with reduction in antibiotic use along with infection-control measures such as contact isolation and hand hygiene with soap and water is essential in the control and prevention of CDI in patients with CKD/ESRD.
PubMed ID
30876614
Volume
26
Issue
1
First Page
30
Last Page
34
